This site is intended for Healthcare professionals only.

Abbott Laboratories reports increased sales and profit in quarterly results


Abbott Laboratories reports increased sales and profit in quarterly results

Diversified healthcare company Abbott Laboratories reported higher-than-expected quarterly sales and profit on Wednesday, driven by its $25 billion acquisition of St. Jude Medical.

Net sales of the company, which consummated its acquisition of St. Jude Medical earlier this year, rose 29.7 percent to $6.34 billion, ahead of the average analyst estimate of $6.15 billion, according to Thomson Reuters I/B/E/S.

Sales rose in three of Abbott’s four core divisions – diagnostics, medical devices and branded generic pharmaceuticals.

Medical device sales rose primarily due to the St. Jude buy, and increased 4.5 percent on a comparable basis to $2.40 billion.

Sales in Abbott’s nutrition business dipped 1 percent on an operational basis to $1.64 billion, hurt mainly by continuing challenging conditions in the Chinese infant formula market.

Excluding items, Abbott earned 48 cents per share, beating the average analyst estimate by 5 cents.

Net profit from continuing operations came in at $843 million, or 22 cents per share, in the first quarter ended March 31, compared with $615 million, or 4 cents per share, a year earlier. The results also reflect St. Jude’s year-over-year results.

Last week, Abbott agreed to buy troubled diagnostics company Alere Inc at a lower price of around $5.30 billion, down from the about $5.80 billion announced in February last year, ending a prolonged legal battle.

 



Source: REUTERS
0 comment(s) on Abbott Laboratories reports increased sales and profit in quarterly results

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted